CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Revenues	$ 9,760,952	$ 1,285,383
Cost of sales	5,504,708	711,650
Gross Profit	4,256,244	573,733
Operating Expenses:
General and administrative	12,260,610	2,732,274
Professional fees	2,696,800	2,703,371
Research and development	4,082,799	29,392
Sales and marketing	3,150,886	40,003
Goodwill impairment	12,357,921
Total Operating Expenses	34,549,016	5,505,040
Loss from Operations	(30,292,772)	(4,931,307)
Other Income (Expense):
Paycheck Protection Program loan forgiveness	108,532
Interest expense	(7,852)	(549)
Loss on disposal of fixed assets	(3,712)	(594)
Other income, net	87,124
Total Other Income (Expense)	184,092	(1,143)
Loss Before Income Taxes	(30,108,680)	(4,932,450)
Provision for income taxes
Net Loss	(30,108,680)	(4,932,450)
Deemed dividends on Series C Preferred Stock and Series D warrants		(4,050,838)
Deemed dividends on redemption of Series D Preferred Stock		(3,763,591)
Deemed dividends on issuance and repurchase of Series E Preferred Stock		(1,227,120)
Series D Preferred stock dividends		(69,778)
Net Loss Available to Common Stockholders	(30,108,680)	(14,043,777)
Comprehensive Loss:
Defined benefit plan liability adjustment, net of tax	(67,903)
Cumulative translation adjustment	(2,691)
Total comprehensive loss, net of tax	$ (30,179,274)	$ (14,043,777)
Net Loss Per Common Share - Basic and Diluted	$ (0.43)	$ (0.35)
Weighted Average Number of Shares Outstanding During the Period -- Basic and Diluted	70,055,832	40,688,019